{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T19:30:06Z","timestamp":1772307006112,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,5,15]],"date-time":"2015-05-15T00:00:00Z","timestamp":1431648000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s00213-015-3956-4","type":"journal-article","created":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T01:50:04Z","timestamp":1431568204000},"page":"1689-1694","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Norepinephrine-enhancing antidepressant exposure associated with reduced antiviral effect of interferon alpha on hepatitis C"],"prefix":"10.1007","volume":"233","author":[{"given":"Renata","family":"Fialho","sequence":"first","affiliation":[]},{"given":"Alison","family":"Burridge","sequence":"additional","affiliation":[]},{"given":"Marco","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"Majella","family":"Keller","sequence":"additional","affiliation":[]},{"given":"Alexandra","family":"File","sequence":"additional","affiliation":[]},{"given":"Jeremy","family":"Tibble","sequence":"additional","affiliation":[]},{"given":"Richard","family":"Whale","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,5,15]]},"reference":[{"key":"3956_CR1","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/j.1440-1746.2011.07035.x","volume":"27","author":"M Alavi","year":"2012","unstructured":"Alavi M, Grebely J, Matthews GV, Petoumenos K, Yeung B, Day C et al (2012) Effect of pegylated interferon-\u03b1-2a treatment on mental health during recent hepatitis C virus infection. J Gastroenterol Hepatol 27:957\u2013965. doi: 10.1111\/j.1440-1746.2011.07035.x","journal-title":"J Gastroenterol Hepatol"},{"key":"3956_CR2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/JCP.0b013e31825d9982","volume":"32","author":"S Baraldi","year":"2012","unstructured":"Baraldi S, Hepgul N, Mondelli V, Pariante CM (2012) Symptomatic treatment of interferon-\u03b1-induced depression in hepatitis C: a systematic review. J Clin Psychopharmacol 32:531\u2013543. doi: 10.1097\/JCP.0b013e31825d9982","journal-title":"J Clin Psychopharmacol"},{"key":"3956_CR3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/npp.2012.191","volume":"38","author":"A Cattaneo","year":"2013","unstructured":"Cattaneo A, Gennarelli M, Uher R, Breen G, Farmer A, Aitchison K et al (2013) Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline \u2018predictors\u2019 and longitudinal \u2018targets\u2019. Neuropsychopharmacology 38:377\u2013385. doi: 10.1038\/npp.2012.191","journal-title":"Neuropsychopharmacology"},{"key":"3956_CR4","doi-asserted-by":"crossref","first-page":"12695","DOI":"10.1073\/pnas.221134198","volume":"98","author":"SW Cole","year":"2001","unstructured":"Cole SW, Naliboff BD, Kemeny ME, Griswold MP, Fahey JL, Zack JA (2001) Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity. Proc Natl Acad Sci U S A 98:12695\u201312700. doi: 10.1073\/pnas.221134198","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3956_CR5","first-page":"806","volume":"59","author":"RB Dimova","year":"2012","unstructured":"Dimova RB, Zeremski M, Jacobson IM, Hagan H, DesJarlais CD, Talal AH (2012) Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis. Clin Infect Dis 59:806\u2013816. doi: 10.1093\/cid\/cis1007","journal-title":"Clin Infect Dis"},{"key":"3956_CR6","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.euroneuro.2012.03.009","volume":"22","author":"J Eccles","year":"2012","unstructured":"Eccles J, Lallemant C, Mushtaq F, Greenwood M, Keller M, Golding B, Tibble J, Haq I, Whale R (2012) Pretreatment waking cortisol response and vulnerability to interferon alpha induced depression. Euro Neuropsychopharmacol 22:892\u2013896. doi: 10.1016\/j.euroneuro.2012.03.009","journal-title":"Euro Neuropsychopharmacol"},{"key":"3956_CR7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/ijcp.12268","volume":"68","author":"M\u202c\u202a Ehret","year":"2014","unstructured":"Ehret M\u202c\u202a, Sobieraj DM (2014) Prevention of interferon-alpha-associated depression with antidepressant medications in patients with hepatitis C virus: a systematic review and meta-analysis. Int J Clin Pract 68:255\u2013261. doi: 10.1111\/ijcp.12268","journal-title":"Int J Clin Pract"},{"key":"3956_CR8","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature04082","volume":"436","author":"JJ Feld","year":"2005","unstructured":"Feld JJ, Hoofnagle JH (2005) Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature 436:967\u2013972. doi: 10.1038\/nature04082","journal-title":"Nature"},{"key":"3956_CR9","volume-title":"Structured Clinical Interview for DSM-IV Axis I Disorders, clinician version (SCID-CV)","author":"MB First","year":"1996","unstructured":"First MB, Spitzer RL, Gibbon M, Williams JBW (1996) Structured Clinical Interview for DSM-IV Axis I Disorders, clinician version (SCID-CV). American Psychiatric Press Inc, Washington DC"},{"key":"3956_CR10","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-140-5-200403020-00010","volume":"140","author":"SJ Hadziyannis","year":"2004","unstructured":"Hadziyannis SJ, Sette H, Morgan TR, Balan V, Diago M, Marcellin P et al (2004) Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 140:346\u2013355. doi: 10.7326\/0003-4819-140-5-200403020-00010","journal-title":"Ann Intern Med"},{"key":"3956_CR11","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1038\/npp.2011.132","volume":"36","author":"J Hannestad","year":"2011","unstructured":"Hannestad J, DellaGioia N, Bloch M (2011) The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 36:2452\u20132459. doi: 10.1038\/npp.2011.132","journal-title":"Neuropsychopharmacology"},{"key":"3956_CR12","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/sj.mp.4001119","volume":"7","author":"P Hauser","year":"2002","unstructured":"Hauser P, Khosla J, Aurora H, Laurin J, Kling MA, Hill J et al (2002) A prospective study of the incidence and open-label treatment of interferon induced major depressive disorder in patients with hepatitis C. Mol Psychiatry 7:942\u2013947. doi: 10.1038\/sj.mp.4001119","journal-title":"Mol Psychiatry"},{"key":"3956_CR13","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jad.2011.10.002","volume":"136","author":"E Henje Blom","year":"2012","unstructured":"Henje Blom E, Lekander M, Ingvar M, Asberg M, Mobarrez F, Serlachius E (2012) Pro-inflammatory cytokines are elevated in adolescent females with emotional disorders not treated with SSRIs. J Affect Disord 136:716\u2013723. doi: 10.1016\/j.jad.2011.10.002","journal-title":"J Affect Disord"},{"key":"3956_CR14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10787-011-0112-6","volume":"20","author":"DL Krause","year":"2012","unstructured":"Krause DL, Riedel M, Muller N, Weidinger E, Schwarz MJ, Myint AM (2012) Effects of antidepressants and cyclooxygenase-2 inhibitor on cytokines and kynurenines in stimulated in vitro blood culture from depressed patients. Inflammopharmacology 20:169\u2013176. doi: 10.1007\/s10787-011-0112-6","journal-title":"Inflammopharmacology"},{"key":"3956_CR15","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nm1780","volume":"14","author":"PA Lang","year":"2008","unstructured":"Lang PA, Contaldo C, Georgiev P, El-Badry AM, Recher M, Kurrer M et al (2008) Aggravation of viral hepatitis by platelet-derived serotonin. Nat Med 14:756\u2013761. doi: 10.1038\/nm1780","journal-title":"Nat Med"},{"key":"3956_CR16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.surge.2011.11.002","volume":"10","author":"M Lesurtel","year":"2012","unstructured":"Lesurtel M, Soll C, Humar B, Clavien PA (2012) Serotonin: a double-edged sword for the liver? Surgeon 10:107\u2013113. doi: 10.1016\/j.surge.2011.11.002","journal-title":"Surgeon"},{"key":"3956_CR17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00001574-200311000-00009","volume":"19","author":"Z Li","year":"2003","unstructured":"Li Z, Diehl AM (2003) Innate immunity in the liver. Curr Opin Gastroenterol 19:565\u2013571. doi: 10.1097\/00001574-200311000-00009","journal-title":"Curr Opin Gastroenterol"},{"key":"3956_CR18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1089\/jir.2010.0074","volume":"31","author":"FE Lotrich","year":"2011","unstructured":"Lotrich FE, Loftis JM, Ferrell RE, Rabinovitz M, Hauser P (2011) IL28B polymorphism is associated with both side effects and clearance of hepatitis C during interferon-alpha therapy. J Interferon Cytokine Res 31:331\u2013336. doi: 10.1089\/jir.2010.0074","journal-title":"J Interferon Cytokine Res"},{"key":"3956_CR19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10787-011-0111-7","volume":"20","author":"M Maes","year":"2012","unstructured":"Maes M, Fisar Z, Medina M, Scapagnini G, Nowak G, Berk M (2012) New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates\u2014Nrf2 activators and GSK-3 inhibitors. Inflammopharmacol 20:127\u2013150. doi: 10.1007\/s10787-011-0111-7","journal-title":"Inflammopharmacol"},{"key":"3956_CR20","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","volume":"65","author":"AH Miller","year":"2009","unstructured":"Miller AH, Maletic V, Raison CL (2009) Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatr 65:732\u2013741. doi: 10.1016\/j.biopsych.2008.11.029","journal-title":"Biol Psychiatr"},{"key":"3956_CR21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.virol.2005.10.002","volume":"345","author":"M Moriuchi","year":"2006","unstructured":"Moriuchi M, Yoshimine H, Oishi K, Moriuchi H (2006) Norepinephrine inhibits human immunodeficiency virus type-1 infection through the NF-\u03baB inactivation. Virology 345:167\u2013173. doi: 10.1016\/j.virol.2005.10.002","journal-title":"Virology"},{"key":"3956_CR22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.neulet.2012.02.087","volume":"514","author":"F Ping","year":"2012","unstructured":"Ping F, Shang J, Zhou J, Zhang H, Zhang L (2012) 5HT (1-A) receptor and apoptosis contribute to interferon alpha induced \u2018depression-like\u2019 behaviour in mice. Neurosci Lett 514:173\u2013178. doi: 10.1016\/j.neulet.2012.02.087","journal-title":"Neurosci Lett"},{"key":"3956_CR23","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.euroneuro.2012.09.009","volume":"23","author":"TR Powell","year":"2013","unstructured":"Powell TR, Schalkwyk LC, Heffernan AL, Breen G, Lawrence T, Price T et al (2013) Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response. Eur Neuropsychopharmacol 23:1105\u20131114. doi: 10.1016\/j.euroneuro.2012.09.009","journal-title":"Eur Neuropsychopharmacol"},{"key":"3956_CR24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","volume":"27","author":"CL Raison","year":"2006","unstructured":"Raison CL, Capuron L, Miller AH (2006) Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 27:24\u201331. doi: 10.1016\/j.it.2005.11.006","journal-title":"Trends Immunol"},{"key":"3956_CR25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/mp.2009.116","volume":"15","author":"CL Raison","year":"2010","unstructured":"Raison CL, Dantzer R, Kelley KW, Lawson MA, Woolwine BJ, Vogt G, Spivey JR, Saito K, Miller AH (2010a) CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol Psychiatry 15:393\u2013403. doi: 10.1038\/mp.2009.116","journal-title":"Mol Psychiatry"},{"key":"3956_CR26","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/mp.2008.58","volume":"15","author":"CL Raison","year":"2010","unstructured":"Raison CL, Borisov AS, Woolwine BJ, Massung B, Vogt G, Miller AH (2010b) Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior. Mol Psychiatry 15:535\u2013547. doi: 10.1038\/mp.2008.58","journal-title":"Mol Psychiatry"},{"key":"3956_CR27","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4088\/PCC.v07n0207b","volume":"7","author":"MA Rifai","year":"2005","unstructured":"Rifai MA (2005) Interferon-\u03b1 treatment of hepatitis C patients with psychiatric illness: evidence-based risk-benefit assessment. Prim Care Companion J Clin Psychiatr 7:74\u201375","journal-title":"Prim Care Companion J Clin Psychiatr"},{"key":"3956_CR28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.psym.2013.06.015","volume":"55","author":"S Sarkar","year":"2014","unstructured":"Sarkar S, Schaefer M (2014) Antidepressant pretreatment for the prevention of interferon alfa-associated depression: a systematic review and meta-analysis. Psychosomatics 55:221\u2013234. doi: 10.1016\/j.psym.2013.06.015","journal-title":"Psychosomatics"},{"key":"3956_CR29","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000102584","volume":"53","author":"A Sch\u00e4fer","year":"2007","unstructured":"Sch\u00e4fer A, Scheurlen M, Weissbrich B, Sch\u00f6ttker K, Kraus MR (2007) Sustained virological response in the antiviral therapy of chronic hepatitis C: is there a predictive value of interferon-induced depression? Chemotherapy 53:292\u2013299. doi: 10.1159\/000102584","journal-title":"Chemotherapy"},{"key":"3956_CR30","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1017\/S0033291713001062","volume":"44","author":"MJ Taylor","year":"2014","unstructured":"Taylor MJ, Godlewska B, Near J, Christmas D, Potokar J, Collier J et al (2014) Effect of interferon-\u03b1 on cortical glutamate in patients with hepatitis C: a proton magnetic resonance spectroscopy study. Psychol Med 44:789\u2013795. doi: 10.1017\/S0033291713001062","journal-title":"Psychol Med"},{"key":"3956_CR31","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbi.2011.12.011","volume":"26","author":"RJ Tynan","year":"2012","unstructured":"Tynan RJ, Weidenhofer J, Hinwood M, Cairns MJ, Day TA, Walker FR (2012) A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia. Brain Behav Immun 26:469\u2013479. doi: 10.1016\/j.bbi.2011.12.011","journal-title":"Brain Behav Immun"},{"key":"3956_CR32","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.4088\/JCP.12r07694","volume":"73","author":"M Udina","year":"2012","unstructured":"Udina M, Castellv\u00ed P, Moreno-Espa\u00f1a J, Navin\u00e9s R, Vald\u00e9s M, Forns X et al (2012) Interferon induced depression in chronic hepatitis C: a systematic review and meta-analysis. J Clin Psychiatry 73:1128\u20131138. doi: 10.4088\/JCP.12r07694","journal-title":"J Clin Psychiatry"},{"key":"3956_CR33","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1176\/appi.ajp.2013.13050709","volume":"171","author":"CS Voican","year":"2014","unstructured":"Voican CS, Corruble E, Naveau S, Perlemuter G (2014) Antidepressant-induced liver injury: a review for clinicians. Am J Psychiatry 171:404\u2013415. doi: 10.1176\/appi.ajp.2013.13050709","journal-title":"Am J Psychiatry"},{"key":"3956_CR34","first-page":"1400","volume":"33","author":"RC Wackernah","year":"2011","unstructured":"Wackernah RC, Lou M, Park SH (2011) Retrospective chart review to assess the relationship between depression and sustained virological response from interferon treatment for hepatitis C virus. ClinTher 33:1400\u20131405. doi: 10.1016\/j.clinthera.2011.09.002","journal-title":"ClinTher"},{"key":"3956_CR35","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/sj.npp.1301029","volume":"31","author":"CB Zhu","year":"2006","unstructured":"Zhu CB, Blakely RD, Hewlett WA (2006) The proinflammatory cytokines interleukin-1b and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 31:2121\u20132131. doi: 10.1038\/sj.npp.1301029","journal-title":"Neuropsychopharmacology"},{"key":"3956_CR36","volume-title":"Neuroscience based nomenclature","author":"J Zohar","year":"2014","unstructured":"Zohar J, Stahl S, Moller H-J et al (2014) Neuroscience based nomenclature. Cambridge University Press, Cambridge"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-015-3956-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-015-3956-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-015-3956-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T02:12:40Z","timestamp":1566699160000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-015-3956-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,15]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["3956"],"URL":"https:\/\/doi.org\/10.1007\/s00213-015-3956-4","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,15]]}}}